As optimism for GLP-1 receptor agonists for weight loss has grown, so too has their use in children. Currently, liraglutide ...

A new weight loss drug target may help reduce appetite and burn calories without causing sickness, research suggests. The discovery could lead to a new treatment for millions of people with both ...

A new study found bariatric ... and determined that between 2022 and 2023, rates of bariatric surgeries dropped by 25%, while prescriptions for weight-loss drugs more than doubled.

GLP-1 Receptor Agonist medications, such as Ozempic, combined with exercise and nutrition, can help reduce obesity, according ...

The new weight-loss drugs have created ... an early-generation GLP-1 drug—cut BMI by at least 5 percent in most participants after 56 weeks. A 2022 trial of 201 teens aged 12 to 18 reported ...

University of Copenhagen - The Faculty of Health and Medical Sciences Scientists at the University of Copenhagen have discovered a new weight loss drug target that reduces appetite, increases ...

Weight loss can be a challenge, even for those who eat healthily and exercise regularly. But injectable type 2 diabetes ...